Skip to main content
SpringerLink
Log in

Bevacizumab/ranibizumab

Medication-related osteonecrosis of the jaws: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Oz I, et al. Medication-related osteonecrosis of the jaws associated with intravitreal administration of ranibizumab. International Journal of Oral and Maxillofacial Surgery 49: 1589-1591, No. 12, Dec 2020. Available from: URL: http://doi.org/10.1016/j.ijom.2020.05.017

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bevacizumab/ranibizumab. Reactions Weekly 1834, 50 (2020). https://doi.org/10.1007/s40278-020-87242-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-87242-5

Search

Navigation